Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
Josephine Paredes, Susan E. Krown(Memorial Sloan Kettering Cancer Center), Lee Ratner(Washington University in St. Louis), Michael Feldstein(Memorial Sloan Kettering Cancer Center), James O. Kahn(San Francisco General Hospital), W P Tong, J M Bennett, Craig E. Metroka, Silan Lin(Memorial Sloan Kettering Cancer Center)
PubMed
June 1, 1995
Cited by 30
Related Papers
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|Journal of Clinical Oncology|1990|785
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483
Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection
|The Journal of Experimental Medicine|2001|385